Antiproliferative and apoptotic effects of telmisartan in human colon cancer cells

Oncology Letters

Volumn 8, Issue 6, 2014, Pages 2681-2686

  Lee, Lucas D ^a   Mafura, Benjamin ^a   Lauscher, Johannes C ^a   Seeliger, Hendrik ^a   Kreis, Martin E ^a   Gröne, Jörn ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiotensin I receptor blocker; Antiproliferative; Apoptosis; Colon cancer; Peroxisome proliferator activated receptor ; Telmisartan

Indexed keywords

PIOGLITAZONE; TELMISARTAN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MTT ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

EID: 84908051433     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2592     Document Type: Article

References (11)

1. Schupp M, Janke J, Clasen R, Unger T and Kintscher U: Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109: 2054-2057, 2004.
2. Mangelsdorf DJ, Thummel C, Beato M, et al: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
3. Fajas L, Fruchart JC and Auwerx J: PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett 438: 55-60, 1998.
4. Matsuyama M, Funao K, Kuratsukuri K, et al: Telmisartan inhibits human urological cancer cell growth through early apoptosis. Exp Ther Med 1: 301-306, 2010.
5. Fajas L, Auboeuf D, Raspé E, et al: The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 272: 18779-18789, 1997.
6. Bull AW: The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch Pathol Lab Med 127: 1121-1123, 2003.
7. Sarraf P, Mueller E, Jones D, et al: Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 4: 1046-1052, 1998.
8. Bertz J, Dahm S, Haberland J, Kraywinkel K, Kurth B-M and Wolf U: Spread of Cancer in Germany. Development in the prevalence between 1990 and 2010. Robert Koch Institute, Berlin, 2010 (In German).
9. Semple TU, Quinn LA, Woods LK and Moore GE: Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res 38: 1345-1355, 1978.
10. Kato M, Kusumi T, Tsuchida S, Tanaka M, Sasaki M and Kudo H: Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone. J Cancer Res Clin Oncol 130: 73-79, 2004.
11. Stangier J, Su CA and Roth W: Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients. J Int Med Res 28: 149-167, 2000.